Pulmonary Drug Delivery Devices Market, Global Outlook and Forecast 2023-2029
Report Code: KNJ1525504 No. of Pages: 127 Category: Medical Devices
Publisher: Date of Publish:
Publisher: Date of Publish:
This report aims to provide a comprehensive presentation of the global market for Pulmonary Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pulmonary Drug Delivery Devices. This report contains market size and forecasts of Pulmonary Drug Delivery Devices in global, including the following market information:
Global Pulmonary Drug Delivery Devices Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Pulmonary Drug Delivery Devices Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Pulmonary Drug Delivery Devices companies in 2022 (%)
The global Pulmonary Drug Delivery Devices market was valued at US$ 2917.7 million in 2022 and is projected to reach US$ 3844.5 million by 2029, at a CAGR of 4.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Dry Powder Inhaler Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pulmonary Drug Delivery Devices include Boehringer Ingelheim GmbH, Novartis AG, GlaxoSmithKline, AstraZeneca, Teva Pharmaceutical Industries, Merck, MannKind, Bristol-Myers Squibb and Mylan N.V, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pulmonary Drug Delivery Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pulmonary Drug Delivery Devices Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pulmonary Drug Delivery Devices Market Segment Percentages, by Type, 2022 (%)
Dry Powder Inhaler
Metered Dose Inhaler
Nebulizer
Global Pulmonary Drug Delivery Devices Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pulmonary Drug Delivery Devices Market Segment Percentages, by Application, 2022 (%)
Asthma
COPD
Cystic Fibrosis
Other
Global Pulmonary Drug Delivery Devices Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pulmonary Drug Delivery Devices Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pulmonary Drug Delivery Devices revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pulmonary Drug Delivery Devices revenues share in global market, 2022 (%)
Key companies Pulmonary Drug Delivery Devices sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Pulmonary Drug Delivery Devices sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim GmbH
Novartis AG
GlaxoSmithKline
AstraZeneca
Teva Pharmaceutical Industries
Merck
MannKind
Bristol-Myers Squibb
Mylan N.V
Omron Corp
F. Hoffmann-La Roche
3M Healthcare
Sunovion Pharmaceuticals
Koninklijke Philips N.V
Gerresheimer AG
Bespak
AptarGroup
SHL Group
Nypro Healthcare
Hovione
Chiesi Farmaceutici S.P.A
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pulmonary Drug Delivery Devices, market overview.
Chapter 2: Global Pulmonary Drug Delivery Devices market size in revenue and volume.
Chapter 3: Detailed analysis of Pulmonary Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pulmonary Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pulmonary Drug Delivery Devices capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Pulmonary Drug Delivery Devices Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pulmonary Drug Delivery Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pulmonary Drug Delivery Devices Overall Market Size
2.1 Global Pulmonary Drug Delivery Devices Market Size: 2022 VS 2029
2.2 Global Pulmonary Drug Delivery Devices Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Pulmonary Drug Delivery Devices Sales: 2018-2029
3 Company Landscape
3.1 Top Pulmonary Drug Delivery Devices Players in Global Market
3.2 Top Global Pulmonary Drug Delivery Devices Companies Ranked by Revenue
3.3 Global Pulmonary Drug Delivery Devices Revenue by Companies
3.4 Global Pulmonary Drug Delivery Devices Sales by Companies
3.5 Global Pulmonary Drug Delivery Devices Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Pulmonary Drug Delivery Devices Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Pulmonary Drug Delivery Devices Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pulmonary Drug Delivery Devices Players in Global Market
3.8.1 List of Global Tier 1 Pulmonary Drug Delivery Devices Companies
3.8.2 List of Global Tier 2 and Tier 3 Pulmonary Drug Delivery Devices Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pulmonary Drug Delivery Devices Market Size Markets, 2022 & 2029
4.1.2 Dry Powder Inhaler
4.1.3 Metered Dose Inhaler
4.1.4 Nebulizer
4.2 By Type - Global Pulmonary Drug Delivery Devices Revenue & Forecasts
4.2.1 By Type - Global Pulmonary Drug Delivery Devices Revenue, 2018-2023
4.2.2 By Type - Global Pulmonary Drug Delivery Devices Revenue, 2024-2029
4.2.3 By Type - Global Pulmonary Drug Delivery Devices Revenue Market Share, 2018-2029
4.3 By Type - Global Pulmonary Drug Delivery Devices Sales & Forecasts
4.3.1 By Type - Global Pulmonary Drug Delivery Devices Sales, 2018-2023
4.3.2 By Type - Global Pulmonary Drug Delivery Devices Sales, 2024-2029
4.3.3 By Type - Global Pulmonary Drug Delivery Devices Sales Market Share, 2018-2029
4.4 By Type - Global Pulmonary Drug Delivery Devices Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pulmonary Drug Delivery Devices Market Size, 2022 & 2029
5.1.2 Asthma
5.1.3 COPD
5.1.4 Cystic Fibrosis
5.1.5 Other
5.2 By Application - Global Pulmonary Drug Delivery Devices Revenue & Forecasts
5.2.1 By Application - Global Pulmonary Drug Delivery Devices Revenue, 2018-2023
5.2.2 By Application - Global Pulmonary Drug Delivery Devices Revenue, 2024-2029
5.2.3 By Application - Global Pulmonary Drug Delivery Devices Revenue Market Share, 2018-2029
5.3 By Application - Global Pulmonary Drug Delivery Devices Sales & Forecasts
5.3.1 By Application - Global Pulmonary Drug Delivery Devices Sales, 2018-2023
5.3.2 By Application - Global Pulmonary Drug Delivery Devices Sales, 2024-2029
5.3.3 By Application - Global Pulmonary Drug Delivery Devices Sales Market Share, 2018-2029
5.4 By Application - Global Pulmonary Drug Delivery Devices Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Pulmonary Drug Delivery Devices Market Size, 2022 & 2029
6.2 By Region - Global Pulmonary Drug Delivery Devices Revenue & Forecasts
6.2.1 By Region - Global Pulmonary Drug Delivery Devices Revenue, 2018-2023
6.2.2 By Region - Global Pulmonary Drug Delivery Devices Revenue, 2024-2029
6.2.3 By Region - Global Pulmonary Drug Delivery Devices Revenue Market Share, 2018-2029
6.3 By Region - Global Pulmonary Drug Delivery Devices Sales & Forecasts
6.3.1 By Region - Global Pulmonary Drug Delivery Devices Sales, 2018-2023
6.3.2 By Region - Global Pulmonary Drug Delivery Devices Sales, 2024-2029
6.3.3 By Region - Global Pulmonary Drug Delivery Devices Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Pulmonary Drug Delivery Devices Revenue, 2018-2029
6.4.2 By Country - North America Pulmonary Drug Delivery Devices Sales, 2018-2029
6.4.3 US Pulmonary Drug Delivery Devices Market Size, 2018-2029
6.4.4 Canada Pulmonary Drug Delivery Devices Market Size, 2018-2029
6.4.5 Mexico Pulmonary Drug Delivery Devices Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Pulmonary Drug Delivery Devices Revenue, 2018-2029
6.5.2 By Country - Europe Pulmonary Drug Delivery Devices Sales, 2018-2029
6.5.3 Germany Pulmonary Drug Delivery Devices Market Size, 2018-2029
6.5.4 France Pulmonary Drug Delivery Devices Market Size, 2018-2029
6.5.5 U.K. Pulmonary Drug Delivery Devices Market Size, 2018-2029
6.5.6 Italy Pulmonary Drug Delivery Devices Market Size, 2018-2029
6.5.7 Russia Pulmonary Drug Delivery Devices Market Size, 2018-2029
6.5.8 Nordic Countries Pulmonary Drug Delivery Devices Market Size, 2018-2029
6.5.9 Benelux Pulmonary Drug Delivery Devices Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Pulmonary Drug Delivery Devices Revenue, 2018-2029
6.6.2 By Region - Asia Pulmonary Drug Delivery Devices Sales, 2018-2029
6.6.3 China Pulmonary Drug Delivery Devices Market Size, 2018-2029
6.6.4 Japan Pulmonary Drug Delivery Devices Market Size, 2018-2029
6.6.5 South Korea Pulmonary Drug Delivery Devices Market Size, 2018-2029
6.6.6 Southeast Asia Pulmonary Drug Delivery Devices Market Size, 2018-2029
6.6.7 India Pulmonary Drug Delivery Devices Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Pulmonary Drug Delivery Devices Revenue, 2018-2029
6.7.2 By Country - South America Pulmonary Drug Delivery Devices Sales, 2018-2029
6.7.3 Brazil Pulmonary Drug Delivery Devices Market Size, 2018-2029
6.7.4 Argentina Pulmonary Drug Delivery Devices Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pulmonary Drug Delivery Devices Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Pulmonary Drug Delivery Devices Sales, 2018-2029
6.8.3 Turkey Pulmonary Drug Delivery Devices Market Size, 2018-2029
6.8.4 Israel Pulmonary Drug Delivery Devices Market Size, 2018-2029
6.8.5 Saudi Arabia Pulmonary Drug Delivery Devices Market Size, 2018-2029
6.8.6 UAE Pulmonary Drug Delivery Devices Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Boehringer Ingelheim GmbH
7.1.1 Boehringer Ingelheim GmbH Company Summary
7.1.2 Boehringer Ingelheim GmbH Business Overview
7.1.3 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Major Product Offerings
7.1.4 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales and Revenue in Global (2018-2023)
7.1.5 Boehringer Ingelheim GmbH Key News & Latest Developments
7.2 Novartis AG
7.2.1 Novartis AG Company Summary
7.2.2 Novartis AG Business Overview
7.2.3 Novartis AG Pulmonary Drug Delivery Devices Major Product Offerings
7.2.4 Novartis AG Pulmonary Drug Delivery Devices Sales and Revenue in Global (2018-2023)
7.2.5 Novartis AG Key News & Latest Developments
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Pulmonary Drug Delivery Devices Major Product Offerings
7.3.4 GlaxoSmithKline Pulmonary Drug Delivery Devices Sales and Revenue in Global (2018-2023)
7.3.5 GlaxoSmithKline Key News & Latest Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Company Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Pulmonary Drug Delivery Devices Major Product Offerings
7.4.4 AstraZeneca Pulmonary Drug Delivery Devices Sales and Revenue in Global (2018-2023)
7.4.5 AstraZeneca Key News & Latest Developments
7.5 Teva Pharmaceutical Industries
7.5.1 Teva Pharmaceutical Industries Company Summary
7.5.2 Teva Pharmaceutical Industries Business Overview
7.5.3 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Major Product Offerings
7.5.4 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales and Revenue in Global (2018-2023)
7.5.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck Pulmonary Drug Delivery Devices Major Product Offerings
7.6.4 Merck Pulmonary Drug Delivery Devices Sales and Revenue in Global (2018-2023)
7.6.5 Merck Key News & Latest Developments
7.7 MannKind
7.7.1 MannKind Company Summary
7.7.2 MannKind Business Overview
7.7.3 MannKind Pulmonary Drug Delivery Devices Major Product Offerings
7.7.4 MannKind Pulmonary Drug Delivery Devices Sales and Revenue in Global (2018-2023)
7.7.5 MannKind Key News & Latest Developments
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Company Summary
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Major Product Offerings
7.8.4 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales and Revenue in Global (2018-2023)
7.8.5 Bristol-Myers Squibb Key News & Latest Developments
7.9 Mylan N.V
7.9.1 Mylan N.V Company Summary
7.9.2 Mylan N.V Business Overview
7.9.3 Mylan N.V Pulmonary Drug Delivery Devices Major Product Offerings
7.9.4 Mylan N.V Pulmonary Drug Delivery Devices Sales and Revenue in Global (2018-2023)
7.9.5 Mylan N.V Key News & Latest Developments
7.10 Omron Corp
7.10.1 Omron Corp Company Summary
7.10.2 Omron Corp Business Overview
7.10.3 Omron Corp Pulmonary Drug Delivery Devices Major Product Offerings
7.10.4 Omron Corp Pulmonary Drug Delivery Devices Sales and Revenue in Global (2018-2023)
7.10.5 Omron Corp Key News & Latest Developments
7.11 F. Hoffmann-La Roche
7.11.1 F. Hoffmann-La Roche Company Summary
7.11.2 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Business Overview
7.11.3 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Major Product Offerings
7.11.4 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales and Revenue in Global (2018-2023)
7.11.5 F. Hoffmann-La Roche Key News & Latest Developments
7.12 3M Healthcare
7.12.1 3M Healthcare Company Summary
7.12.2 3M Healthcare Pulmonary Drug Delivery Devices Business Overview
7.12.3 3M Healthcare Pulmonary Drug Delivery Devices Major Product Offerings
7.12.4 3M Healthcare Pulmonary Drug Delivery Devices Sales and Revenue in Global (2018-2023)
7.12.5 3M Healthcare Key News & Latest Developments
7.13 Sunovion Pharmaceuticals
7.13.1 Sunovion Pharmaceuticals Company Summary
7.13.2 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Business Overview
7.13.3 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Major Product Offerings
7.13.4 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales and Revenue in Global (2018-2023)
7.13.5 Sunovion Pharmaceuticals Key News & Latest Developments
7.14 Koninklijke Philips N.V
7.14.1 Koninklijke Philips N.V Company Summary
7.14.2 Koninklijke Philips N.V Business Overview
7.14.3 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Major Product Offerings
7.14.4 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Sales and Revenue in Global (2018-2023)
7.14.5 Koninklijke Philips N.V Key News & Latest Developments
7.15 Gerresheimer AG
7.15.1 Gerresheimer AG Company Summary
7.15.2 Gerresheimer AG Business Overview
7.15.3 Gerresheimer AG Pulmonary Drug Delivery Devices Major Product Offerings
7.15.4 Gerresheimer AG Pulmonary Drug Delivery Devices Sales and Revenue in Global (2018-2023)
7.15.5 Gerresheimer AG Key News & Latest Developments
7.16 Bespak
7.16.1 Bespak Company Summary
7.16.2 Bespak Business Overview
7.16.3 Bespak Pulmonary Drug Delivery Devices Major Product Offerings
7.16.4 Bespak Pulmonary Drug Delivery Devices Sales and Revenue in Global (2018-2023)
7.16.5 Bespak Key News & Latest Developments
7.17 AptarGroup
7.17.1 AptarGroup Company Summary
7.17.2 AptarGroup Business Overview
7.17.3 AptarGroup Pulmonary Drug Delivery Devices Major Product Offerings
7.17.4 AptarGroup Pulmonary Drug Delivery Devices Sales and Revenue in Global (2018-2023)
7.17.5 AptarGroup Key News & Latest Developments
7.18 SHL Group
7.18.1 SHL Group Company Summary
7.18.2 SHL Group Business Overview
7.18.3 SHL Group Pulmonary Drug Delivery Devices Major Product Offerings
7.18.4 SHL Group Pulmonary Drug Delivery Devices Sales and Revenue in Global (2018-2023)
7.18.5 SHL Group Key News & Latest Developments
7.19 Nypro Healthcare
7.19.1 Nypro Healthcare Company Summary
7.19.2 Nypro Healthcare Business Overview
7.19.3 Nypro Healthcare Pulmonary Drug Delivery Devices Major Product Offerings
7.19.4 Nypro Healthcare Pulmonary Drug Delivery Devices Sales and Revenue in Global (2018-2023)
7.19.5 Nypro Healthcare Key News & Latest Developments
7.20 Hovione
7.20.1 Hovione Company Summary
7.20.2 Hovione Business Overview
7.20.3 Hovione Pulmonary Drug Delivery Devices Major Product Offerings
7.20.4 Hovione Pulmonary Drug Delivery Devices Sales and Revenue in Global (2018-2023)
7.20.5 Hovione Key News & Latest Developments
7.21 Chiesi Farmaceutici S.P.A
7.21.1 Chiesi Farmaceutici S.P.A Company Summary
7.21.2 Chiesi Farmaceutici S.P.A Business Overview
7.21.3 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Major Product Offerings
7.21.4 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Sales and Revenue in Global (2018-2023)
7.21.5 Chiesi Farmaceutici S.P.A Key News & Latest Developments
8 Global Pulmonary Drug Delivery Devices Production Capacity, Analysis
8.1 Global Pulmonary Drug Delivery Devices Production Capacity, 2018-2029
8.2 Pulmonary Drug Delivery Devices Production Capacity of Key Manufacturers in Global Market
8.3 Global Pulmonary Drug Delivery Devices Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pulmonary Drug Delivery Devices Supply Chain Analysis
10.1 Pulmonary Drug Delivery Devices Industry Value Chain
10.2 Pulmonary Drug Delivery Devices Upstream Market
10.3 Pulmonary Drug Delivery Devices Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pulmonary Drug Delivery Devices Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com